Dyslipidemia in kidney receiver
Background. Kidney transplantation is the gold standard of treatment in patients with a terminal renal failure. Nevertheless, the main reason for death of recipients, loss of the renal allograft is cardiovascular disease, and disorder of lipid profile remains one of the most significant risk factors...
Main Authors: | S. M. Martirosyan, E. D. Kosmacheva |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Kubankurortresurs, OOO
2019-06-01
|
Series: | Инновационная медицина Кубани |
Subjects: | |
Online Access: | https://inovmed.elpub.ru/jour/article/view/196 |
Similar Items
-
Data assessment of cardiovascular system remodeling in patients prior and after kidney transplantation
by: S. M. Martirosyan, et al.
Published: (2019-02-01) -
Dyslipidemia in patients with chronic kidney disease: etiology and management
by: Mikolasevic I, et al.
Published: (2017-02-01) -
The use of statin drugs in patients with chronic kidney disease, combined with dyslipidemia
by: D.D. Ivanov, et al.
Published: (2015-04-01) -
DYSLIPIDEMIA AS A FACTOR FOR PROGRESSION OF RENAL OSTEODYSTROPHY AND CORONARY HEART DISEASE IN PATIENTS WITH CHRONIC KIDNEY DISEASE ON PERITONEAL DIALYSIS
by: V. Lesovoy, et al.
Published: (2017-12-01) -
Apolipoproteins: Good Markers for Cardiovacular Risk in Patients with Chronic Kidney Disease and Dyslipidemia
by: Tudor Mirela - Nicoleta, et al.
Published: (2014-09-01)